Inhibition of the growth of hepatoma and hepatic metastasis by pingyangmycin conjugated with Fab' fragment of monoclonal antibody

X. Liu, B. Shang, X. Liu

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

OBJECTIVE: To develop an immunoconjugate with inhibitory effect on the growth of hepatoma and hepatic metastasis of tumor by linking Fab' fragment of monoclona antibody (McAb) to pingyangmycin (PYM). METHODS: Monoclonal antibody Fab' fragment was obtained by enzymolysis with pepsin and DTT reduction. Linking of the Fab' fragment and PYM was mediated by dextran T40. Indirect ELISA, TTC bacteriostatic titer test, clonogenic assay and animal models transplanted with tumor were used to assess the biological activities and antitumor effects of Fab' PYM conjugate within and without the bodies of 10 mice. RESULTS: The Fab' PYM conjugate showed immunoreactivity to BEL7402, hepatoma 22 (H22) and HT29 cells, but no reaction to KB cells. The bacteriostatic activity of PYM in the conjugate was 15% as much as that of free PYM. The 50% inhibitory doses (IC50) of Fab'PYM conjugate to BEL7402, HT29 cells and KB cells were 0.02 micromol/L, 0.08 micromol/L and 0.50 micromol/L respectively. Given intravenously, 10 mg/kg x 6, Fab' PYM conjugate and PYM suppressed the growth of hepatoma 22 by 86% and 62% respectively. Given intraperitoneally, 10 mg/kg x 4, Fab' PYM and PYM decreased the hepatic metastasis of colon carcinoma 26 by 91% and 62% respectively. CONCLUSION: Fab' PYM conjugate is more effective in combating hepatoma and hepatic metastasis of tumor than free PYM.

Original languageEnglish (US)
Pages (from-to)201-204
Number of pages4
JournalZhonghua yi xue za zhi
Volume81
Issue number4
StatePublished - Feb 25 2001

Fingerprint

Immunoglobulin Fab Fragments
Hepatocellular Carcinoma
Monoclonal Antibodies
Neoplasm Metastasis
Liver
Growth
KB Cells
HT29 Cells
bleomycetin
Immunoconjugates
Neoplasms
Immunoglobulin Fragments
Pepsin A
Dextrans
Inhibitory Concentration 50
Colon

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Inhibition of the growth of hepatoma and hepatic metastasis by pingyangmycin conjugated with Fab' fragment of monoclonal antibody. / Liu, X.; Shang, B.; Liu, X.

In: Zhonghua yi xue za zhi, Vol. 81, No. 4, 25.02.2001, p. 201-204.

Research output: Contribution to journalArticle

@article{ced76dc1b020416587280f09688f4b02,
title = "Inhibition of the growth of hepatoma and hepatic metastasis by pingyangmycin conjugated with Fab' fragment of monoclonal antibody",
abstract = "OBJECTIVE: To develop an immunoconjugate with inhibitory effect on the growth of hepatoma and hepatic metastasis of tumor by linking Fab' fragment of monoclona antibody (McAb) to pingyangmycin (PYM). METHODS: Monoclonal antibody Fab' fragment was obtained by enzymolysis with pepsin and DTT reduction. Linking of the Fab' fragment and PYM was mediated by dextran T40. Indirect ELISA, TTC bacteriostatic titer test, clonogenic assay and animal models transplanted with tumor were used to assess the biological activities and antitumor effects of Fab' PYM conjugate within and without the bodies of 10 mice. RESULTS: The Fab' PYM conjugate showed immunoreactivity to BEL7402, hepatoma 22 (H22) and HT29 cells, but no reaction to KB cells. The bacteriostatic activity of PYM in the conjugate was 15{\%} as much as that of free PYM. The 50{\%} inhibitory doses (IC50) of Fab'PYM conjugate to BEL7402, HT29 cells and KB cells were 0.02 micromol/L, 0.08 micromol/L and 0.50 micromol/L respectively. Given intravenously, 10 mg/kg x 6, Fab' PYM conjugate and PYM suppressed the growth of hepatoma 22 by 86{\%} and 62{\%} respectively. Given intraperitoneally, 10 mg/kg x 4, Fab' PYM and PYM decreased the hepatic metastasis of colon carcinoma 26 by 91{\%} and 62{\%} respectively. CONCLUSION: Fab' PYM conjugate is more effective in combating hepatoma and hepatic metastasis of tumor than free PYM.",
author = "X. Liu and B. Shang and X. Liu",
year = "2001",
month = "2",
day = "25",
language = "English (US)",
volume = "81",
pages = "201--204",
journal = "Zhonghua yi xue za zhi",
issn = "0376-2491",
publisher = "Zhonghua Yixuehui Zazhishe",
number = "4",

}

TY - JOUR

T1 - Inhibition of the growth of hepatoma and hepatic metastasis by pingyangmycin conjugated with Fab' fragment of monoclonal antibody

AU - Liu, X.

AU - Shang, B.

AU - Liu, X.

PY - 2001/2/25

Y1 - 2001/2/25

N2 - OBJECTIVE: To develop an immunoconjugate with inhibitory effect on the growth of hepatoma and hepatic metastasis of tumor by linking Fab' fragment of monoclona antibody (McAb) to pingyangmycin (PYM). METHODS: Monoclonal antibody Fab' fragment was obtained by enzymolysis with pepsin and DTT reduction. Linking of the Fab' fragment and PYM was mediated by dextran T40. Indirect ELISA, TTC bacteriostatic titer test, clonogenic assay and animal models transplanted with tumor were used to assess the biological activities and antitumor effects of Fab' PYM conjugate within and without the bodies of 10 mice. RESULTS: The Fab' PYM conjugate showed immunoreactivity to BEL7402, hepatoma 22 (H22) and HT29 cells, but no reaction to KB cells. The bacteriostatic activity of PYM in the conjugate was 15% as much as that of free PYM. The 50% inhibitory doses (IC50) of Fab'PYM conjugate to BEL7402, HT29 cells and KB cells were 0.02 micromol/L, 0.08 micromol/L and 0.50 micromol/L respectively. Given intravenously, 10 mg/kg x 6, Fab' PYM conjugate and PYM suppressed the growth of hepatoma 22 by 86% and 62% respectively. Given intraperitoneally, 10 mg/kg x 4, Fab' PYM and PYM decreased the hepatic metastasis of colon carcinoma 26 by 91% and 62% respectively. CONCLUSION: Fab' PYM conjugate is more effective in combating hepatoma and hepatic metastasis of tumor than free PYM.

AB - OBJECTIVE: To develop an immunoconjugate with inhibitory effect on the growth of hepatoma and hepatic metastasis of tumor by linking Fab' fragment of monoclona antibody (McAb) to pingyangmycin (PYM). METHODS: Monoclonal antibody Fab' fragment was obtained by enzymolysis with pepsin and DTT reduction. Linking of the Fab' fragment and PYM was mediated by dextran T40. Indirect ELISA, TTC bacteriostatic titer test, clonogenic assay and animal models transplanted with tumor were used to assess the biological activities and antitumor effects of Fab' PYM conjugate within and without the bodies of 10 mice. RESULTS: The Fab' PYM conjugate showed immunoreactivity to BEL7402, hepatoma 22 (H22) and HT29 cells, but no reaction to KB cells. The bacteriostatic activity of PYM in the conjugate was 15% as much as that of free PYM. The 50% inhibitory doses (IC50) of Fab'PYM conjugate to BEL7402, HT29 cells and KB cells were 0.02 micromol/L, 0.08 micromol/L and 0.50 micromol/L respectively. Given intravenously, 10 mg/kg x 6, Fab' PYM conjugate and PYM suppressed the growth of hepatoma 22 by 86% and 62% respectively. Given intraperitoneally, 10 mg/kg x 4, Fab' PYM and PYM decreased the hepatic metastasis of colon carcinoma 26 by 91% and 62% respectively. CONCLUSION: Fab' PYM conjugate is more effective in combating hepatoma and hepatic metastasis of tumor than free PYM.

UR - http://www.scopus.com/inward/record.url?scp=0035946048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035946048&partnerID=8YFLogxK

M3 - Article

C2 - 11798873

AN - SCOPUS:0035946048

VL - 81

SP - 201

EP - 204

JO - Zhonghua yi xue za zhi

JF - Zhonghua yi xue za zhi

SN - 0376-2491

IS - 4

ER -